Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$8.21 - $18.59 $821,000 - $1.86 Million
-100,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.33 - $19.81 $203,940 - $356,580
18,000 Added 21.95%
100,000 $1.86 Million
Q2 2020

Aug 14, 2020

BUY
$4.2 - $15.45 $344,400 - $1.27 Million
82,000 New
82,000 $934,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Odey Asset Management Group LTD Portfolio

Follow Odey Asset Management Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Odey Asset Management Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Odey Asset Management Group LTD with notifications on news.